A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Rob Pieters, Martin Schrappe, Paola De Lorenzo, +17

The Lancet

Hematological MalignancyAcute Lymphoblastic LeukaemiaOncologyPediatric EpidemiologyPediatric Hematology +5

Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood

Menrvi Taskinen, Ulla M. Saarinen‐Pihkala, Liisa Hovi, +1

The Lancet

ObesityMetabolic SyndromeTransplantationBone-marrow TransplantationBone Marrow Failure +10

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Gertjan J.L. Kaspers, Martin Zimmermann, Dirk Reinhardt, +16

Journal of Clinical Oncology

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years

Liisa Hovi, UM Saarinen‐Pihkala, Kim Vettenranta, +1

Bone Marrow Transplantation

TransplantationMarrow TransplantationPediatric HematologySingle Center ExperienceHematology +4

Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials

Sverre O. Lie, Jonas Abrahamsson, Niels Clausen, +9

Leukemia

Pediatric EpidemiologyPediatric HematologyClinical TrialsPediatricsConsecutive Trials +3

Acute leukaemia in children with Down syndrome: a population‐based Nordic study

Bernward Zeller, Göran Gustafsson, Erik Forestier, +8

British Journal of Haematology

Treatment stratification based on initial <i>in vivo</i> response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO‐AML trials

Sverre O. Lie, Jonas Abrahamsson, Niels Clausen, +6

British Journal of Haematology

Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children

Päivi Hölttä, Satu Alaluusua, Ulla M. Saarinen‐Pihkala, +2

Cancer

Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation

Päivi Hölttä, Satu Alaluusua, UM Saarinen‐Pihkala, +3

Bone Marrow Transplantation

Neuro-oncologyPoor-risk NeuroblastomaRadiation TherapyPediatricsTotal Body Irradiation +5

Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol

Marieke H. van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, +14

Blood